News
Androgen deprivation therapy, also known as hormone therapy, is the gold standard of care for men whose prostate cancer is advanced and has spread throughout the body.
When we use androgen deprivation therapy, we are lowering testosterone levels typically by turning off the testes from making testosterone. This starves cancer cells, causing them to shut down, ...
Androgen deprivation therapy is commonly used to treat prostate cancer, often on an open-ended basis for therapy of advanced prostate cancer. It is estimated that 44 percent of men with prostate ...
Many patients can live long lives due to early detection and treatment with androgen deprivation therapy. However, despite the benefits of this therapy, ... Jun 15, 2022 0 84 page 1 from 10 « » ...
It has been over 70 years since the initial description of prostate cancer androgen dependence by Huggins and Hodges leading to androgen deprivation becoming a mainstay treatment for the disease.
Androgen deprivation therapy suppresses the production of testosterone, the male hormone said to fuel growth of prostate cancer. The therapy improves survival when given with radiation for later ...
Androgen deprivation therapy (ADT) for prostate cancer is associated with decreased bone mineral density (BMD) in patients. This decreased BMD can lead to an increased risk of fractures and ...
Earlier this year, the addition of Nubeqa to docetaxel and androgen deprivation therapy was shown to lower hospitalization rates among patients with metastatic hormone-sensitive prostate cancer but ...
Androgen deprivation therapy with or without other systemic therapy is the standard treatment for metastatic prostate cancer, but has numerous adverse effects that can decrease quality of life ...
Association of Androgen Deprivation Therapy With Alzheimer’s Disease: Unmeasured Confounders Androgen Deprivation Therapy and Risk of Alzheimer’s Disease: Importance of Holistic Geriatric Oncology ...
June 11, 2009 — Androgen-deprivation therapy (ADT) for prostate cancer is overused, according to experts who have written recent editorials in 2 major journals.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results